Lori Kunkel
Director/Board Member at ORIC PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Heyman | M | 66 | 10 years | |
| Jacob van Naarden | M | 39 | 10 years | |
| Samuel Kintz | M | 38 | 5 years | |
| Diantha Duvall | F | 52 | 2 years | |
| Jacob Chacko | M | 45 | 6 years | |
| Arthur Sands | M | 62 | 10 years | |
| Terrence Connolly | M | - |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | - |
| Jason Daniel Kantor | M | - | 4 years | |
| Joseph Lyssikatos | M | 59 | 5 years | |
| Christine Ring | M | 59 | 5 years | |
| David Lacey | M | 71 | 8 years | |
| Judith Reinsdorf | F | 60 | 3 years | |
| Steven Hoerter | M | 53 | 3 years | |
| Paul Silva | M | 58 | 3 years | |
| Andrew Phillips | M | 53 | 1 years | |
| Robert DuBridge | M | - |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 8 years |
| John Hohneker | M | 64 | 3 years | |
| Anish Patel | M | 43 | 5 years | |
| Edward Saltzman | M | 69 | 2 years | |
| Jake Bauer | M | 45 | 1 years | |
| Julia Gregory | F | 71 | 5 years | |
| James Scibetta | M | 59 |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 7 years |
| Rishi Gupta | M | 46 | 1 years | |
| Terry Connolly | F | - |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | 3 years |
| Angie You | M | 51 | 3 years | |
| Mika Derynck | M | 61 | 1 years | |
| Mardi Dier | F | 60 | 4 years | |
| Dora Ferrari | F | - | 3 years | |
| Paula O’Connor | M | - | 2 years | |
| Galya Blachman | M | 47 | - | |
| Buckley Kohlhauff | M | - | 3 years | |
| Gwenn Hansen | M | 53 | 9 years | |
| Hans van Houte | M | 58 | 9 years | |
| Kimberly Steinmann | M | - | 2 years | |
| Raf Lambrecht | M | - | 4 years | |
| Lori Friedman | M | 60 | 5 years | |
| Sunitha Ramamurthy | F | - | 6 years | |
| Rahul Ballal | M | 46 | 1 years | |
| Reinhard von Roemeling | M | - | 5 years | |
| Matthew Panuwat | M | 47 | 6 years | |
| Helen Collins | M | 62 | 1 years | |
| Dominic Piscitelli | M | 50 | 5 years | |
| Michael T. Lotze | M | - | 4 years | |
| Edna Maneval | M | 64 | 5 years | |
| Betty Chang | M | - | 11 years | |
| Thorsten Graef | M | - | 11 years | |
| Chong Xu | M | 43 |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | - |
| Pratik Multani | M | 57 | 6 years | |
| Christian V. Kuhlen | M | 51 | - | |
| Eric C. Schlezinger | M | - | 2 years | |
| Jason Rhodes | M | 54 |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | - |
| Michael Heffernan | M | 59 |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | - |
| William Greene | M | - |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 5 years |
| Benjamin Hohl | M | 35 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harry E. Gruber | M | 72 | 13 years | |
| Josh Bilenker | M | 52 | 6 years | |
| Dennis Berman | M | 73 | 10 years | |
| Ali Fattaey | M | 59 | 5 years | |
| William Steinkrauss | M | 39 | 6 years | |
| Peter Svennilson | M | 62 | 7 years | |
| Timothy Kutzkey | M | 49 | 10 years | |
| Dov Goldstein | M | 56 | 2 years | |
| Arlene Morris | F | 72 | 4 years | |
| James McNab | M | 80 | 17 years | |
| Paul Wagner | M | 53 | - | |
| Sean P. Lance | M | 77 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 6 years |
| Manmeet Singh Soni | M | 46 | 3 years | |
| Robert A. Swanson | M | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Kenneth J. Pienta | M | 64 | 4 years | |
| Ingrid Boyes | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| Jennifer Burstein | F | 52 | 4 years | |
| Joshua Brumm | M | 46 | 1 years | |
| Matthew Outten | M | 49 | 5 years | |
| David Tuck | M | 72 | 3 years | |
| Leon E. Chen | M | 49 | 1 years | |
| Hans-Peter Gerber | M | - |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 2 years |
| Stephen Brady | M | 54 |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | 3 years |
| Raymond Jeffrey Kmetz | M | - | 6 years | |
| Robert Tjian | M | 74 | 4 years | |
| Jesse Seton McGreivy | M | 54 | - | |
| Mani Mohindru | M | 52 | 4 years | |
| Kenneth Clark | M | 65 | 3 years | |
| Roy C. Hardiman | M | 64 | 2 years | |
| Jeffrey Tong | M | 48 | 4 years | |
| Marianne T. Armstrong | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 3 years |
| Helen Kim | F | 61 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | 9 years |
| Eric H. Halvorson | M | 74 | 4 years | |
| Myrtle Potter | F | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
| Richard B. Love | M | 62 | - | |
| Eric Hedrick | M | 59 | 2 years | |
| Martin Duvall | M | 62 | 4 years | |
| Alan Fuhrman | M | 67 | 4 years | |
| Franklin Berger | M | 74 | 6 years | |
| Paul Schimmel | M | 83 | 5 years | |
| Hal R. Werner | M | 75 | 8 years | |
| Sarah Hymowitz | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 22 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 96 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lori Kunkel
- Personal Network
